Related investigations reported that DEPDC1B is overexpressed in various cancer types, such as breast cancer, oral cancer, non-small-cell lung cancer, melanoma cancer, bladder cancer and prostate cancer [11, 12, 14, 16–20]. Here, DEPDC1B is linked to urinary bladder carcinoma.